|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.340 USD | +0.75% |
|
+5.56% | -26.92% |
| 07-22 | Alzamend Neuro, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 | CI |
| 07-21 | Alzamend Neuro, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Evolution of the Average Target: Alzamend Neuro, Inc.
Evolution of the Target Price: Alzamend Neuro, Inc.
Changes in Analyst Recommendations: Alzamend Neuro, Inc.
3381abf38eee2334b.8CCYoh6MpC4SCRpi515cFuYNLCWHHs8Nq9LOIY5m90U.lGTq407iyhkgRX4jrww4Ra5gAUPwKJx-0oOidsZflA6KU8LjZOnjeypCKg~3871173b4125b27110f7188e7276e1ea
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +1,779.7% | |||
| +23.65% | |||||
| +9.39% | |||||
| +27.54% | |||||
| +11.51% | |||||
| +44.52% | |||||
| -5.11% | |||||
| +19.93% | |||||
| +8.58% | |||||
| +9.68% | |||||
| Average | +192.94% | |||||
| Weighted average by Cap. | +18.83% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.330USD
Average target price
25.00USD
Spread / Average Target
+1,779.70%
High Price Target
25.00USD
Spread / Highest target
+1,779.70%
Low Price Target
25.00USD
Spread / Lowest Target
+1,779.70%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Maxim | |
| Ascendiant Capital |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.330USD
Average target price
25.00USD
Spread / Average Target
+1,779.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALZN Stock
- Consensus Alzamend Neuro, Inc.
Select your edition
All financial news and data tailored to specific country editions
